Table 3.
Variable | Per unit for HR | univariate |
multivariate |
||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | ||
Age | 1-year | 1.003 | 0.991–1.015 | .632 | |||
Sex | Male/female | 1.663 | 1.248–2.215 | <.001 | 0.787 | 0.504–1.228 | .291 |
Smoking status | Ever/never | 1.976 | 1.457–2.680 | <.001 | 1.746 | 1.069–2.854 | .026 |
Histology | Adenocarcinoma/the other histologies | 1.763 | 1.350–2.303 | <.001 | 1.123 | 0.818–1.54 | .473 |
Pathological stage | 1-stage | 2.433 | 2.109–2.807 | <.001 | 2.293 | 1.93–2.72 | <.001 |
EGFR mutation | Mutant/wild type | 0.696 | 0.501–0.966 | .03 | 0.917 | 0.628–1.339 | .654 |
Adjuvant chemotherapy | Yes/no | 1.403 | 1.095–1.798 | .007 | 1.084 | 0.808–1.454 | .588 |
YTHDF1 | High/low | 0.664 | 0.518–0.850 | .001 | 0.745 | 0.564–0.984 | .038 |
YTHDF2 | High/low | 0.67 | 0.508–0.885 | .005 | 0.683 | 0.503–0.928 | .014 |